GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

Redx has suspended trading of its shares after a creditor stepped up its attempt to recoup a loan.

A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.

The big China CRO WuXi Biologics is slated for an initial public offering of up to $513 million in Hong Kong.

The U.K. has been closing the gap on life sciences sectors in Boston and San Francisco, but uncertainty caused by Brexit may undermine those efforts, said the…

​​​​​​​Cel-Sci’s pitch to get a partial clinical hold lifted by the FDA has gone awry.

Roche Diabetes Care rolled out its latest blood glucose meter along with a new savings program for test strips, which the company says could save patients up…

Pierre Fabre, the second biggest biopharma in France (after Big Pharma Sanofi), is boosting its cancer pipeline with what it is dubbing “promising” immuno-…

Debiopharm has bought a phase 2 antibody-drug conjugate (ADC) from ImmunoGen to add to its clinical-phase cancer pipeline.